Clinical Trial Update: Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients

View source ↗

Summary

This completed clinical trial evaluated the QuantiFERON-CMV assay as a predictor of CMV infection in high-risk solid organ transplant recipients. The results in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• QuantiFERON-CMV

Snippet

Sponsor: University of Alberta | Conditions: Cytomegalovirus Infection | Status: COMPLETED